Multiple-tumor aberrant growth genes

Details for Australian Patent Application No. 2003200883 (hide)

Owner Vlaams Interuniversitair Instituut voor Biotechnologie vzw Bullerdiek, J.

Inventors Bullerdiek, Jorn; Schoenmakers, Henricus Franciscus Petrus Maria; Mols, Rafael; Van de Ven, Willem Jan Marie

Agent Baldwin Shelston Waters

Pub. Number AU-A-2003200883

Parent 25203

Filing date 28 February 2003

Wipo publication date 12 June 2003

International Classifications

C12N 015/12 Mutation or genetic engineering - Genes encoding animal proteins

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C07K 016/18 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C07K 014/47 Peptides having more than 20 amino acids

C07K 019/00 Hybrid peptides

A61K 038/17 Medicinal preparations containing peptides - from animals

A01K 067/027 Rearing or breeding animals, not otherwise provided for - New breeds of vertebrates

Event Publications

27 March 2003 Complete Application Filed

12 June 2003 Application Open to Public Inspection

  Published as AU-A-2003200883

1 March 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003200884-Therapeutic compounds comprised of anti-Fc receptor antibodies

2003200882-Surface-modified nanoparticles and method of making and using same